yr 〜
yr

Search results 47

Rifaximin enhances the L‑carnitine‑mediated preventive effects on skeletal muscle atrophy in cirrhotic rats by modulating the gut‑liver‑muscle axis

Rifaximin enhances the L‑carnitine‑mediated preventive effects on skeletal muscle atrophy in cirrhotic rats by modulating the gut‑liver‑muscle axis
Digital博士論文障害者向け資料あり
Murata, Koji, Kaji, Kosuke, Nishimura, Norihisa, Enomoto, Masahide, Fujimoto, Yuki, Takeda, Soichi, Tsuji, Yuki, Fujinaga, Yukihisa, Takaya, Hiroaki, Kawaratani, Hideto, Namisaki, Tadashi, Akahane, Takemi, Yoshiji, HitoshiSpandidos Publications2022-08
National Diet Library
  • Author Heading...akaya, Hiroaki Kawaratani, Hideto Namisaki, Tadashi Akahane, Ta...

Angiotensin Receptor Blockers Potentiate the Protective Effect of Branched-Chain Amino Acids on Skeletal Muscle Atrophy in Cirrhotic Rats

Angiotensin Receptor Blockers Potentiate the Protective Effect of Branched-Chain Amino Acids on Skeletal Muscle Atrophy in Cirrhotic Rats
Digital博士論文障害者向け資料あり
Takeda, Soichi, Kaji, Kosuke, Nishimura, Norihisa, Enomoto, Masahide, Fujimoto, Yuki, Murata, Koji, Takaya, Hiroaki, Kawaratani, Hideto, Moriya, Kei, Namisaki, Tadashi, Akahane, Takemi, Yoshiji, HitoshiWiley2021-12
National Diet Library
  • Author Heading...akaya, Hiroaki Kawaratani, Hideto Moriya, Kei Namisaki, Tadashi...

Dual therapy with zinc acetate and rifaximin prevents from ethanolinduced liver fibrosis by maintaining intestinal barrier integrity

Dual therapy with zinc acetate and rifaximin prevents from ethanolinduced liver fibrosis by maintaining intestinal barrier integrity
Digital博士論文障害者向け資料あり
Fujimoto, Yuki, Kaji, Kosuke, Nishimura, Norihisa, Enomoto, Masahide, Murata, Koji, Takeda, Soichi, Takaya, Hiroaki, Kawaratani, Hideto, Moriya, Kei, Namisaki, Tadashi, Akahane, Takemi, Yoshiji, HitoshiBaishideng Publishing Group2021-12-28
National Diet Library
  • Author Heading...akaya, Hiroaki Kawaratani, Hideto Moriya, Kei Namisaki, Tadashi...

Rifaximin and lubiprostone mitigate liver fibrosis development by repairing gut barrier function in diet–induced rat steatohepatitis

Rifaximin and lubiprostone mitigate liver fibrosis development by repairing gut barrier function in diet–induced rat steatohepatitis
Digital博士論文障害者向け資料あり
Enomoto, Masahide, Kaji, Kosuke, Nishimura, Norihisa, Fujimoto, Yuki, Murata, Koji, Takeda, Soichi, Tsuji, Yuki, Fujinaga, Yukihisa, Tanaka, Hiroaki, Kawaratani, Hideto, Namisaki, Tadashi, Akahane, Takemi, Yoshiji, HitoshiElsevier2022-10
National Diet Library
  • Author Heading...anaka, Hiroaki Kawaratani, Hideto Namisaki, Tadashi Akahane, Ta...

Lenvatinib prevents liver fibrosis by inhibiting hepatic stellate cell activation and sinusoidal capillarization in experimental liver fibrosis. 25 8

Lenvatinib prevents liver fibrosis by inhibiting hepatic stellate cell activation and sinusoidal capillarization in experimental liver fibrosis. 25 8
Digital博士論文障害者向け資料あり
Ogawa, Hiroyuki, Kaji, Kosuke, Nishimura, Norihisa, Takagi, Hirotetsu, Ishida, Koji, Takaya, Hiroaki, Kawaratani, Hideto, Moriya, Kei, Namisaki, Tadashi, Akahane, Takemi, Yoshiji, HitoshiJohn Wiley & Sons2021-04Journal of cellular and molecular medicine Vol. No. p.- (2021 Apr)
National Diet Library
  • Author Heading...akaya, Hiroaki Kawaratani, Hideto Moriya, Kei Namisaki, Tadashi...

Sulforaphane ameliorates ethanol plus carbon tetrachloride-induced liver fibrosis in mice through the Nrf2-mediated antioxidant response and acetaldehyde metabolization with inhibition of the LPS/TLR4 signaling pathway. 89

Sulforaphane ameliorates ethanol plus carbon tetrachloride-induced liver fibrosis in mice through the Nrf2-mediated antioxidant response and acetaldehyde metabolization with inhibition of the LPS/TLR4 signaling pathway. 89
Digital博士論文障害者向け資料あり
Ishida, Koji, Kaji, Kosuke, Sato, Shinya, Ogawa, Hiroyuki, Takagi, Hirotetsu, Takaya, Hiroaki, Kawaratani, Hideto, Moriya, Kei, Namisaki, Tadashi, Akahane, Takemi, Yoshiji, HitoshiElsevier2021-03The Journal of nutritional biochemistry
National Diet Library
  • Author Heading...akaya, Hiroaki Kawaratani, Hideto Moriya, Kei Namisaki, Tadashi...

The Angiotensin II Receptor Blocker Losartan Sensitizes Human Liver Cancer Cells to Lenvatinib-Mediated Cytostatic and Angiostatic Effects. 10 3

The Angiotensin II Receptor Blocker Losartan Sensitizes Human Liver Cancer Cells to Lenvatinib-Mediated Cytostatic and Angiostatic Effects. 10 3
Digital博士論文障害者向け資料あり
Takagi, Hirotetsu, Kaji, Kosuke, Nishimura, Norihisa, Ishida, Koji, Ogawa, Hiroyuki, Takaya, Hiroaki, Kawaratani, Hideto, Moriya, Kei, Namisaki, Tadashi, Akahane, Takemi, Mitoro, Akira, Yoshiji, HitoshiMDPI2021-03-05Cells
National Diet Library
  • Author Heading...akaya, Hiroaki Kawaratani, Hideto Moriya, Kei Namisaki, Tadashi...

Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis. 8 6

Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis. 8 6
Digital博士論文障害者向け資料あり
Tsuji, Yuki, Kaji, Kosuke, Kitade, Mitsuteru, Kaya, Daisuke, Kitagawa, Koh, Ozutsumi, Takahiro, Fujinaga, Yukihisa, Takaya, Hiroaki, Kawaratani, Hideto, Namisaki, Tadashi, Moriya, Kei, Akahane, Takemi, Yoshiji, HitoshiMDPI2020-06-19Microorganisms
National Diet Library
  • Author Heading...akaya, Hiroaki Kawaratani, Hideto Namisaki, Tadashi Moriya, Kei...

TGR5 Activation Modulates an Inhibitory Effect on Liver Fibrosis Development Mediated by Anagliptin in Diabetic Rats. 8 10

TGR5 Activation Modulates an Inhibitory Effect on Liver Fibrosis Development Mediated by Anagliptin in Diabetic Rats. 8 10
Digital博士論文障害者向け資料あり
Kaya, Daisuke, Kaji, Kosuke, Tsuji, Yuki, Yamashita, Satoko, Kitagawa, Koh, Ozutsumi, Takahiro, Fujinaga, Yukihisa, Takaya, Hiroaki, Kawaratani, Hideto, Moriya, Kei, Namisaki, Tadashi, Akahane, Takemi, Yoshiji, HitoshiMDPI2019-09-26Cells
National Diet Library
  • Author Heading...akaya, Hiroaki Kawaratani, Hideto Moriya, Kei Namisaki, Tadashi...

Angiotensin receptor blockade attenuates cholangiocarcinoma cell growth by inhibiting the oncogenic activity of Yes-associated protein. 434

Angiotensin receptor blockade attenuates cholangiocarcinoma cell growth by inhibiting the oncogenic activity of Yes-associated protein. 434
Digital博士論文障害者向け資料あり
Saikawa, Soichiro, Kaji, Kosuke, Nishimura, Norihisa, Seki, Kenichiro, Sato, Shinya, Nakanishi, Keisuke, Kitagawa, Koh, Kawaratani, Hideto, Kitade, Mitsuteru, Moriya, Kei, Namisaki, Tadashi, Mitoro, Akira, Yoshiji, HitoshiElsevier2018-10-10Cancer letters
National Diet Library
  • Author Heading... Kitagawa, Koh Kawaratani, Hideto Kitade, Mitsuteru Moriya, Kei...

Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis. 21 15

Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis. 21 15
Digital博士論文障害者向け資料あり
Fujinaga, Yukihisa, Kawaratani, Hideto, Kaya, Daisuke, Tsuji, Yuki, Ozutsumi, Takahiro, Furukawa, Masanori, Kitagawa, Koh, Sato, Shinya, Nishimura, Norihisa, Sawada, Yasuhiko, Takaya, Hiroaki, Kaji, Kosuke, Shimozato, Naotaka, Moriya, Kei, Namisaki, Tadashi, Akahane, Takemi, Mitoro, Akira, Yoshiji, HitoshiMDPI2020-08-04International journal of molecular sciences
National Diet Library
  • Author HeadingFujinaga, Yukihisa Kawaratani, Hideto Kaya, Daisuke Tsuji, Yuki Ozu...

Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis. 21 6

Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis. 21 6
Digital博士論文障害者向け資料あり
Ozutsumi, Takahiro, Namisaki, Tadashi, Shimozato, Naotaka, Kaji, Kosuke, Tsuji, Yuki, Kaya, Daisuke, Fujinaga, Yukihisa, Furukawa, Masanori, Nakanishi, Keisuke, Sato, Shinya, Sawada, Yasuhiko, Saikawa, Soichiro, Kitagawa, Koh, Takaya, Hiroaki, Kawaratani, Hideto, Kitade, Mitsuteru, Moriya, Kei, Noguchi, Ryuichi, Akahane, Takemi, Mitoro, Akira, Yoshiji, HitoshiMDPI2020-03-21International journal of molecular sciences
National Diet Library
  • Author Heading...akaya, Hiroaki Kawaratani, Hideto Kitade, Mitsuteru Moriya, Kei...

Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model. 20 11

Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model. 20 11
Digital博士論文障害者向け資料あり
Nakanishi, Keisuke, Kaji, Kosuke, Kitade, Mitsuteru, Kubo, Takuya, Furukawa, Masanori, Saikawa, Soichiro, Shimozato, Naotaka, Sato, Shinya, Seki, Kenichiro, Kawaratani, Hideto, Moriya, Kei, Namisaki, Tadashi, Yoshiji, HitoshiMDPI2019-06-03International journal of molecular sciences
National Diet Library
  • Author Heading...eki, Kenichiro Kawaratani, Hideto Moriya, Kei Namisaki, Tadashi...

Oral administration of fructose exacerbates liver fibrosis and hepatocarcinogenesis via increased intestinal permeability in a rat steatohepatitis model. 9 47

Oral administration of fructose exacerbates liver fibrosis and hepatocarcinogenesis via increased intestinal permeability in a rat steatohepatitis model. 9 47
Digital博士論文障害者向け資料あり
Seki, Kenichiro, Kitade, Mitsuteru, Nishimura, Norihisa, Kaji, Kosuke, Asada, Kiyoshi, Namisaki, Tadashi, Moriya, Kei, Kawaratani, Hideto, Okura, Yasushi, Takaya, Hiroaki, Sawada, Yasuhiko, Sato, Shinya, Nakanishi, Keisuke, Yoshiji, HitoshiImpact Journals2018-06-19Oncotarget
National Diet Library
  • Author Heading...hi Moriya, Kei Kawaratani, Hideto Okura, Yasushi Takaya, Hiroak...

Combining probiotics and an angiotensin-II type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non-alcoholic steatohepatitis. 49 3

Combining probiotics and an angiotensin-II type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non-alcoholic steatohepatitis. 49 3
Digital博士論文障害者向け資料あり
Sawada, Yasuhiko, Kawaratani, Hideto, Kubo, Takuya, Fujinaga, Yukihisa, Furukawa, Masanori, Saikawa, Soichiro, Sato, Shinya, Seki, Kenichiro, Takaya, Hiroaki, Okura, Yasushi, Kaji, Kosuke, Shimozato, Naotaka, Mashitani, Tsuyoshi, Kitade, Mitsuteru, Moriya, Kei, Namisaki, Tadashi, Akahane, Takemi, Mitoro, Akira, Yamao, Junichi, Yoshiji, HitoshiWiley2019-03Hepatology research
National Diet Library
  • Author HeadingSawada, Yasuhiko Kawaratani, Hideto Kubo, Takuya Fujinaga, Yukihi...

Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis. 50 7

Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis. 50 7
Digital博士論文障害者向け資料あり
Furukawa, Masanori, Moriya, Kei, Nakayama, Jiro, Inoue, Takako, Momoda, Rie, Kawaratani, Hideto, Namisaki, Tadashi, Sato, Shinya, Douhara, Akitoshi, Kaji, Kosuke, Kitade, Mitsuteru, Shimozato, Naotaka, Sawada, Yasuhiko, Saikawa, Soichiro, Takaya, Hiroaki, Kitagawa, Koh, Akahane, Takemi, Mitoro, Akira, Yamao, Junichi, Tanaka, Yasuhito, Yoshiji, HitoshiWiley2020-07Hepatology research
National Diet Library
  • Author Heading...ko Momoda, Rie Kawaratani, Hideto Namisaki, Tadashi Sato, Shiny...

Combination of L-Carnitine and Angiotensin-II type 1 Receptor Blocker has Beneficial Effects on Hepatic Fibrosis in a Non-Alcoholic Steatohepatitis Rat Model. 23 5

Combination of L-Carnitine and Angiotensin-II type 1 Receptor Blocker has Beneficial Effects on Hepatic Fibrosis in a Non-Alcoholic Steatohepatitis Rat Model. 23 5
Digital博士論文障害者向け資料あり
Kubo, Takuya, Kawaratani, Hideto, Sawada, Yasuhiko, Fujinaga, Yukihisa, Ozutsumi, Takahiro, Kaya, Daisuke, Tsuji, Yuki, Nakanishi, Keisuke, Furukawa, Masanori, Kitagawa, Kou, Saikawa, Soichiro, Sato, Shinya, Takaya, Hiroaki, Kaji, Kosuke, Shimozato, Naotaka, Moriya, Kei, Namisaki, Tadashi, Akahane, Takemi, Mitoro, Akira, Yoshiji, HitoshiBiomedical Research Network+2019-12Biomedical journal of scientific and technical research
National Diet Library
  • Author HeadingKubo, Takuya Kawaratani, Hideto Sawada, Yasuhiko Fujinaga, Yu...

Sulforaphane Inhibits Liver Cancer Cell Growth and Angiogenesis. 6 4

Sulforaphane Inhibits Liver Cancer Cell Growth and Angiogenesis. 6 4
Digital博士論文障害者向け資料あり
Sato, Shinya, Moriya, Kei, Furukawa, Masanori, Saikawa, Soichiro, Namisaki, Tadashi, Kitade, Mitsuteru, Kawaratani, Hideto, Kaji, Kosuke, Takaya, Hiroaki, Shimozato, Naotaka, Sawada, Yasuhiko, Seki, Kenichiro, Kitagawa, Kou, Akahane, Takemi, Mitoro, Akira, Okura, Yasushi, Yoshiji, Hitoshi, Yamao, JunichiiMedPub LTD2018-12Archives in cancer research
National Diet Library
  • Author Heading...ade, Mitsuteru Kawaratani, Hideto Kaji, Kosuke Takaya, Hiroaki ...

Periostin cross‑reacts with the renin‑angiotensin system during liver fibrosis development. 16 5

Periostin cross‑reacts with the renin‑angiotensin system during liver fibrosis development. 16 5
Digital博士論文障害者向け資料あり
Takeda, Kosuke, Noguchi, Ryuichi, Kitade, Mitsuteru, Namisaki, Tadashi, Moriya, Kei, Kawaratani, Hideto, Okura, Yasushi, Kaji, Kosuke, Aihara, Yosuke, Douhara, Akitoshi, Nishimura, Norihisa, Sawada, Yasuhiko, Seki, Kenichiro, Yoshiji, HitoshiSpandidos Publications2017-11Molecular medicine reports
National Diet Library
  • Author Heading...hi Moriya, Kei Kawaratani, Hideto Okura, Yasushi Kaji, Kosuke A...

Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a non-diabetic rat model of steatohepatitis. 47 12

Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a non-diabetic rat model of steatohepatitis. 47 12
Digital博士論文障害者向け資料あり
Okura, Yasushi, Namisaki, Tadashi, Moriya, Kei, Kitade, Mitsuteru, Takeda, Kosuke, Kaji, Kosuke, Noguchi, Ryuichi, Nishimura, Norihisa, Seki, Kenichiro, Kawaratani, Hideto, Takaya, Hiroaki, Sato, Shinya, Sawada, Yasuhiko, Shimozato, Naotaka, Furukawa, Masanori, Nakanishi, Keisuke, Saikawa, Soichiro, Kubo, Takuya, Asada, Kiyoshi, Yoshiji, HitoshiJohn Wiley & Sons, Inc.2016-12-28Hepatology research
National Diet Library
  • Author Heading...eki, Kenichiro Kawaratani, Hideto Takaya, Hiroaki Sato, Shinya ...